biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
16:11 Certain gut bacteria linked to slower or faster aging in 123 adults✦16:10 One-time gene edit let 2 of 3 patients stop daily starch, maker says✦10:20 EU approves Enhertu after surgery for a high-risk breast cancer type✦10:17 A pill given around surgery delayed prostate cancer spread in a big trial✦10:13 Mayo studies in mice point to new ways to tame aging 'zombie' cells✦04:22 Targeted drug cut death risk 32% in advanced womb cancer, report says✦04:18 A Stanford 'company' of 37,000 AI programs studied 50,000 drug trials✦04:18 FDA approves pill pair for earlier prostate cancer with DNA-repair flaws✦16:11 Certain gut bacteria linked to slower or faster aging in 123 adults✦16:10 One-time gene edit let 2 of 3 patients stop daily starch, maker says✦10:20 EU approves Enhertu after surgery for a high-risk breast cancer type✦10:17 A pill given around surgery delayed prostate cancer spread in a big trial✦10:13 Mayo studies in mice point to new ways to tame aging 'zombie' cells✦04:22 Targeted drug cut death risk 32% in advanced womb cancer, report says✦04:18 A Stanford 'company' of 37,000 AI programs studied 50,000 drug trials✦04:18 FDA approves pill pair for earlier prostate cancer with DNA-repair flaws
← All story threadsSTORY THREAD

Merck's targeted drug for womb cancer.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 26, 2026
    BIG TRIAL: LOWER RISK OF DEATH, REPORTS SAYBig trial · results in news

    Targeted drug cut death risk 32% in advanced womb cancer, report says

    Trade press reported that a Merck drug, which carries chemotherapy straight to tumor cells, lowered the risk of death by 32% versus standard chemotherapy in women whose womb cancer came back after earlier treatment.